Stay updated with breaking news from France Early Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data, which were previously presented at the American Society of Hematology (ASH) Annual Meeting in December 2022, includes results of 81 patients with gastrointestinal acute Graft-versus-Host Disease
Data, which were previously presented at the American Society of Hematology (ASH) Annual Meeting in December 2022, includes results of 81 patients with gastrointestinal acute Graft-versus-Host Disease (GI-aGvHD) treated with MaaT013 as part of a compassionate use program in France, and results of the Phase 1b CIMON...
Oral presentation at 64th American Society of Hematology Annual Meeting includes promising results from 81 patients with steroid-resistant, gastrointestinal acute Graft-versus-Host Disease (GI-aGvHD) treated with MaaT013 as part of compassionate use program (Early Access Program or EAP) in France.Results showed a GI...
Oral presentation at 63rd American Society of Hematology Annual Meeting includes results from the HERACLES Phase 2 trial in 24 patients with steroid-resistant Grade III-IV gastrointestinal acute